Sign In
Buy LLY
$1,083.23
+18.39 (+1.73%)
At Close: Jun 03, 2026
Bank of American: Lilly's tirzepatide could be the first $100 billion drug
10:31am, Friday, 07'th Oct 2022
Bank of America analysts on Friday told investors that Eli Lilly & Co. Inc.'s LLY, -0.93% diabetes treatment and possible weight-management drug could be a $100 billion medication. The drug, tirzepati
4 Stocks That Can Turn $100,000 Into $500,000 by the Time You Retire
06:25am, Friday, 07'th Oct 2022
This quartet of stocks has plenty of growth ahead and is already profitable.
FDA ‘fast tracks' Eli Lilly's obesity drug: ‘this is the Holy Grail'
05:15pm, Thursday, 06'th Oct 2022
Eli Lilly & Co (NYSE: LLY) is in focus on Thursday after the pharmaceutical giant said the U.S. FDA agreed to a speedy review of Tirzepatide for the treatment of obesity and weight-related comorbiditi
Eli Lilly's experimental obesity drug could be 'revolutionary,' says Jim Cramer
11:22am, Thursday, 06'th Oct 2022
CNBC's Jim Cramer and the 'Squawk on the Street' team discuss shares of Eli Lilly after the U.S. Food and Drug Administration granted the company a fast-track designation for its obesity drug.
One Of Eli Lilly's Most Anticipated Drugs Could Hit The Market Next Year
09:43am, Thursday, 06'th Oct 2022
Eli Lilly said Thursday it plans to begin the process of asking the FDA to approve its obesity treatment. LLY stock rose on the news.
Lilly gets Fast Track designation for its experimental obesity drug
07:57am, Thursday, 06'th Oct 2022
Eli Lilly and Co. LLY, +0.57% said Thursday that its experimental obesity drug received a Fast Track designation from the Food and Drug Administration. The drug maker also said it plans to begin a rol
Better Alzheimer's Disease Stock: Eli Lilly or Biogen?
10:00am, Wednesday, 05'th Oct 2022
One of these stocks has significantly outperformed the other over the past year. Will that continue?
These Were The Five Best And Worst Performing Mega-Cap Stocks In September 2022
08:02pm, Tuesday, 04'th Oct 2022
September has historically been the weakest month for the U.S. stock market, and 2022 was no different.
Is Eli Lilly Stock a Buy Following This Competitor's Major Win?
10:37am, Monday, 03'rd Oct 2022
Eli Lilly's recent jump could be short-lived.
On CNBC's “Halftime Report Final Trades,” Bryn Talkington of Requisite Capital Management said Pacer US Cash Cows 100 ETF (BATS: COWZ) is “a factor-b
3 Growth Stocks Poised to Skyrocket
10:37am, Saturday, 01'st Oct 2022
Two of these three stocks are already soaring this year.
Gina Sanchez makes a bull case for Eli Lilly & Co
08:11am, Saturday, 01'st Oct 2022
Eli Lilly & Co (NYSE: LLY) will continue to do well even as the U.S. Federal Reserve aggressively lift rates further, says Gina Sanchez – the Chief Executive of Chantico Global.
Eli Lilly's Donanemab: Nearing The End Of The Line For Anti-Amyloid Drugs
12:41am, Saturday, 01'st Oct 2022
Anti-amyloid drugs only modestly slow down the progression of Alzheimer's disease in APOE4 carriers and have no effect on non-carriers. APOE4 carriers have more amyloid in their brain so removing the
Leading Drugmaker Eli Lilly Reaches All-Time High, Briefly, On Alzheimer's Hopes
03:40pm, Friday, 30'th Sep 2022
Eli Lilly ranks first in the diversified health care group. The post Leading Drugmaker Eli Lilly Reaches All-Time High, Briefly, On Alzheimer's Hopes appeared first on Investor's Business Daily.
Chantico Global CEO Gina Sanchez offers 3 buys and a bail: LLY, WMT, MSFT & GPS
02:43pm, Friday, 30'th Sep 2022
Gina Sanchez, Chantico Global CEO, joins ‘The Exchange' to discuss her three investment picks for being defensive in the market and one stock to sell.
